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Highlights: 
 
 Early Warning Scores are commonly used to assess patients in hospital 
 The available evidence suggests they are inaccurate at predicting mortality 
 The cannot rule in (LR+ 1.79) or rule out (LR- 0.59) mortality 
 The studies involved are generally at moderate-high risk of bias 
 
Abstract 
Objectives 
Early Warning scores are used to evaluate patients in many hospital settings. It is not clear if 
these are accurate in predicting mortality in sepsis. We performed a systematic review and 
meta-analysis of multiple studies in sepsis. Our aim was to estimate the accuracy of EWS for 
mortality in this setting.  
 
Methods 
PubMED, CINAHL, Cochrane, Web of Science and EMBASE were searched to October 2016. 
Studies of adults with sepsis who had EWS calculated using any appropriate tool (e.g. NEWS, 
MEWS) were eligible for inclusion. Study quality was assessed using QUADAS-2.  Summary 
estimates were derived using HSROC analysis. 
 
Results 
Six studies (4,298 participants) were included. Results suggest that EWS cannot be used to 
predict which patients with sepsis will (positive likelihood ratio 1.79, 95% CI 1.53 to 2.11) or 
will not die (negative likelihood ratio 0.59, 95% CI 0.45 to 0.78). Two studies were rated as 
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low risk of bias and one as unclear risk of bias on all domains.  The other three studies were 
judged at high risk of bias in one domain. 
 
Conclusion 
Early Warning Scores are not sufficiently accurate to rule in or rule out mortality in patients 
with sepsis, based on the evidence available, which is generally poor quality. 
 
Keywords: sepsis; mortality; Early Warning scores; infection; scoring 
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 Introduction 
Sepsis is a major problem in emergency departments and hospitals causing significant 
morbidity and mortality.1,2 A steady increase in the incidence of sepsis has been noted 
worldwide, with recent UK estimates of around 50 cases of severe sepsis per 100,000 
people per year.3 Collecting data on accurate mortality figures is difficult, but recent 
estimates suggest an estimated case mortality of between 20-35%, although rates differ 
widely by definition.4,5 Timely diagnosis of patients with sepsis can be difficult, because of 
the differences in clinical presentations, and few uniquely identifying features, especially in 
the elderly.6  
 
Once patients with sepsis are identified, rapid treatment has been shown to improve 
mortality, although nearly all evidence comes from observational studies.7–9 Due to the 
significant number of patients who present with sepsis, it is critical to identify the patients at 
risk of deterioration, and patients requiring urgent treatment or critical care input.  
Alongside this, there is also a need to identify the significant number of patients who are 
likely to have a good outcome and hence can be managed more conservatively.   
 
Early Warning Scores (EWS) are physiological composite scores comprising pulse rate, blood 
pressure, temperature, respiratory rate, mental state and oxygen saturation. Each of these 
physical observations are given a score, where 0 is considered normal. Simple addition of 
these observations allows a total score to be calculated, usually between 0 and 12.  
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Different versions of EWS often have minor modifications, such as the addition of points if 
the patient is receiving oxygen therapy, or variations in specific cut-offs. 
 
 
Recently, the UK National Institute for Health and Care Excellence (NICE) has published 
guidelines on the recognition, diagnosis and management of sepsis.10 These guidelines 
recommend considering the use of Early Warning Scores in assessing patients with 
suspected sepsis in acute hospital settings, and highlight this area as a key research topic. 
The 2015 National Confidential Enquiry on Patient Outcome and Death report on sepsis also 
suggested use of EWS as a principal recommendation in all care settings, specifically to 
assess severity of sepsis and to prioritise urgent care.11 
 
 
Over the last ten years, EWS have been introduced into nearly all UK hospitals, and are 
already recommended in NICE guidance for monitoring critically ill patients in hospital and 
Royal College of Physician guidance for monitoring of all adult patients in acute hospital 
settings, .12,13 They have recently been introduced into emergency departments, and also 
into many ambulances services and community settings and primary care.14 Given these 
scores are often calculated on every patient, there have been concerns about the volume of 
workload created and the sensitivity of these scores for identifying unwell patients.15 
 
EWS are often used, both informally and formally, to guide treatment decisions such as the 
best location for care (inpatient, outpatient, ICU), and the level of monitoring or seniority of 
doctor that should see the patient. In some centres, a certain score (for example, greater 
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than 5), will trigger a pager alert to senior medical staff or critical care outreach services. 
Although there is some evidence that this method identifies sick patients, the evidence 
relating to patients with sepsis is limited.16,17  
 
 
Methods 
A protocol was developed based on recommended standards for conduct of systematic 
reviews.18,19 The review was registered with PROSPERO (CRD42016047125), and the PRISMA 
guidelines were followed when reporting results. 
 
Study identification 
MEDLINE, EMBASE, CINAHL, the Cochrane Library, and Web of Science were searched from 
inception to October 2016.  The search strategy combined terms for sepsis with terms for 
EWS. The full search study is available as a web appendix. References of included studies 
were screened and all first authors emailed to identify additional relevant studies. 
 
Study Selection 
Studies were eligible for inclusion if they assessed any form of Early Warning Score for the 
prediction of mortality in adult patients with sepsis. Studies were required to report 
sufficient data to construct a 22 table of test performance. Studies on a particular type of 
infection (e.g. meningitis) or a particular microbial cause (e.g Streptococcus pneumoniae) 
were excluded. Studies were limited to secondary care facilities.  A diagnosis of sepsis was 
considered as any diagnosis made prospectively or retrospectively by physicians, and coded 
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as such. Mortality data was ideally 28-day mortality, but any form of mortality reporting was 
accepted. Mortality was chosen as this is the most commonly reported and most important 
outcome in sepsis.  
 
Two reviewers (AB, DA) independently screened titles and abstracts identified by the search. 
Full text articles considered potentially relevant were obtained. Inclusion assessment was 
performed by  a third reviewer (FH); disagreements were resolved through consensus 
between all three. 
 
Data extraction and quality assessment 
Data on study design, number of participants, country, setting, EWS methodology, 
definitions of sepsis, mortality, sensitivity, specificity and area under the curve (AOC) were 
extracted using a predesigned form. If studies did not publish 2 x 2 data, this was calculated 
from the number of participants, sensitivity, specificity, and mortality. Where studies 
reported more than one set of 2x2 data, for example for different thresholds, then each set 
of 2x2 data was extracted. Study quality was assessed using the QUADAS-2 tool.20  We 
modified our QUADAS assessment to look specifically at whether studies were biased by the 
use of EWS reducing mortality. If an EWS was in use and was acted on, this would be 
expected to impact on mortality and so would bias any estimate of the accuracy of NEWS in 
predicting mortality. This is because EWS should identify patients who are deteriorating and 
action should have been taken which may have reduced mortality - known as treatment 
paradox in the context of diagnostic test evaluation. Data extraction and quality assessment 
were carried out by one reviewer and checked by a second. Disagreements were resolved 
through discussion. 
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 Data synthesis and analysis 
We calculated sensitivity and specificity for each set of 2x2 data and plotted these in 
summary receiver operating characteristic (SROC) space. Where studies reported data for 
multiple thresholds, data for the threshold most similar to that in other studies were 
extracted.  Only one set of 2x2 data per study contributed to the analysis.  The 
bivariate/hierarchical summary receiver operating characteristic (HSROC) models were used 
to estimate summary sensitivity and specificity with 95% confidence and prediction regions 
around the summary points and to derive an HSROC curve.  This approach allows for 
between-study heterogeneity in sensitivity and specificity, and for the trade-off (negative 
correlation) between sensitivity and specificity commonly seen in diagnostic meta-analyses.  
Heterogeneity was assessed visually using the SROC plot. Summary positive and negative 
likelihood ratios were derived from the summary estimates of sensitivity and specificity.  We 
also estimated the summary area under the ROC (AUC) by pooling AUCs reported in 
individual studies using a random effects model.  We used  Stata 13 (StataCorp LP, College 
Station, Texas, USA), mainly using the metandi .21command and using MedCalc for Windows, 
version 15.0 (MedCalc Software, Ostend, Belgium). 
 
We conducted sensitivity analysis to investigate the effect of type of early warning score, 
study quality, setting, and threshold.  Analyses were restricted to studies that were 
considered at low risk of bias or low/unclear concerns regarding applicability across all 
QUADAS-2 domains, to studies conducted in the ED, and to studies that used a threshold of 
≥5 to define a positive EWS result.   We also conducted subgroup analyses stratified 
according to type of EWS. 
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 A flow diagram was created to put these results into clinical context.  This shows the results 
that would be obtained if EWS were used in a hypothetical population of 1000 patients 
presenting to the emergency department with sepsis where 150 (15%) will die. This figure 
was chosen as the average mortality across our six studies was around this.  
 
Results 
Figure 1 shows the flow of studies through the review process. The searches identified 620 
possible studies, of which 6 were included (4,298 participants). Two of the studies were 
conducted in the UK 22,23, and  one each  in Germany24, Israel25, Italy26 and Turkey27 (Table 1). 
The Italian study was available as a conference abstract only. 
 
Four studies were performed in emergency departments22–24,27; two were in internal 
medicine. 25,26 Three studies were relatively small in size (<400 participants),23,24,27 one was 
moderate (n=535)26 and two included more than 1000 participants.22,25 Five studies used 
the MEWS system, one study used the National Early Warning Score (NEWS), a slight 
variation.13,22 NEWS and MEWS both include respiration rate, oxygen saturation, 
supplemental oxygen, temperature, blood pressure, heart rather and level of consciousness.  
The NEWS score includes scoring for oxygen saturation, whereas the MEWS score includes 
scoring for urine output.  
 
Three studies used the American College of Chest Physicians / Society of Critical Care 
Medicine (ACCP/SCCM) consensus definition as the basis of their sepsis diagnoses.22,25,27 
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One study was conducted across two sites, one site used the consensus definition, the other 
used a ‘clinician suspicion of infection’ alongside evidence that blood cultures had been 
drawn.23 One study only reported that patients has “objectively diagnosed sepsis.”26  The 
final study concentrated on ‘suspected sepsis’ using some of the ACCP/SCCM definition or a 
‘working diagnosis that included sepsis’.24 Two studies were retrospective case note 
reviews22,23, three identified sepsis prospectively.25–27 One study24 used prospective 
identification, but allowed retrospective case note review to ensure no missed cases. 
 
 Two studies were judged at low risk of bias for all QUADAS domains (Table 2). The Italian 
study, 26 which was available only as an abstract, was judged as unclear risk of bias for all 
domains except the reference standard domain for which it was judged as low risk of bias.   
This is because insufficient information was available to reach a judgement for the other 
domains.  Three studies were rated at high risk for bias in terms of flow and timing. These 
were all prospective studies that recorded EWS in real time. This leads to the potential to 
them being acted upon – the ‘treatment paradox’, and hence lowering mortality and biasing 
our estimate of EWS accuracy.24,25,27 There were some concerns regarding the applicability 
of studies to the review question.  The Italian study was judged at unclear concerns 
regarding applicability for all domains due to the lack of information available.  There were 
high concerns about the applicability of the population in one study24.  Diagnostic criteria for 
sepsis were ‘suspected sepsis’ rather than confirmed sepsis and more than 20% of patients 
included had a final diagnosis that was not sepsis.  The applicability of the index test (EWS) 
was considered as unclear in four studies as the time point at which the EWS was performed 
was not documented (i.e – whether on admission to hospital, or during the stay in the 
ED).23,24,26,27  Given that EWS are based on physiology, and hence change continually and 
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with treatment, there was the potential for this to have affected the applicability of results 
if EWS had not been recorded on admission.  One study was considered at high concern 
regarding applicability.24 The definition of mortality in this study was in hospital mortality 
compared to our outcome of interest of 30 day mortality.  The accuracy of EWS for 
prediction of mortality at this time point may be different and so this was flagged as a high 
concern regarding applicability.  
 
Estimates of sensitivity and specificity showed considerable heterogeneity across studies.  
Specificity ranged from 34 to 89%, and specificity from 30 to 84% (Table 1).  The summary 
ROC plot (figure 2) shows individual study estimates of sensitivity and specificity, the 
summary estimate across studies and the HSROC curve. Individual estimates of sensitivity 
and specificity were close to the HSROC curve, suggesting that much of the variation across 
studies was a result of the trade-off between sensitivity and specificity. The area under the 
curve (AUC) was more similar across studies, ranging from 0.59 to 0.72 with a summary AUC 
of 0.68 (95% CI 0.65, 0.71; 5 studies).  Summary sensitivity was 66% (95% CI 46, 81%), and 
summary specificity was 62% (95% CI 45, 76%) based on all six studies.  These estimates 
should be interpreted with some caution due to the observed heterogeneity.  There was 
less heterogeneity in likelihood ratios with positive likelihood ratios ranging from 1.27 to 
2.06 and negative likelihood ratios ranging from 0.33 to 0.79.  The summary positive 
likelihood ratio was 1.79 (95% CI 1.53, 2.11) and summary negative likelihood ratio was 0.59 
(95% CI 0.45, 0.78).  These suggest that EWS cannot be used to rule in or rule out mortality.   
 
We investigated the effect of study quality, type of EWS, threshold and setting on results 
(Table 3).  We restricted analysis to studies at low risk of bias (n=2), studies with low 
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concern regarding applicability (n=2), studies with low or unclear concerns regarding 
applicability (n=5), studies conducted in emergency departments (n=4), studies that 
evaluated the MEWS score (n=5) and studies that defined a score of 5 or more as a positive 
EWS result (4 studies).  There was evidence that accuracy varied according to type of EWS, 
all other sensitivity analysis showed similar results.    Analyses stratified on type of EWS 
suggested that MEWS is slightly better for predicting mortality (LR+ 1.90, 1.66 to 2.18; 5 
studies, Figure 3 ) than NEWS (LR+ 1.27, 1.22 to 1.34; 1 study) but worse at ruling out 
mortality (LR- 0.66, 0.55 to 0.80 compared to 0.33, 0.24 to 0.47  for NEWS).  The accuracy 
was still not sufficient to predict or rule out mortality.  Only one study evaluated NEWS22 but 
this was the largest study included in the review and was considered at low risk of bias.     
 
To put the above figures in context, Figure 4 shows that in theory, if EWS were to be used in 
a group of 1000 patients presenting to the emergency department where 150 (15%) will die, 
an estimated 422 will have an EWS predicting mortality but only 99 (24%) will actually die.  
Of the 578 people with a result suggesting they will not die, 51 (9%) will die. 
 
Discussion 
Summary of findings 
We identified six relevant studies for inclusion in our review.   Results suggest that EWS 
cannot be used to predict who will (positive likelihood ratio 1.79, 95% CI 1.53, 2.11) or will 
not (negative likelihood ratio 0.59, 95% CI 0.45, 0.78) die in patients with sepsis.  Sensitivity 
analyses suggested that results were similar when restricted to studies at low risk of bias, 
studies with low concern regarding applicability, studies with low or unclear concerns 
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regarding applicability, studies conducted in emergency departments, and studies that 
defined a score of 5 or more as a positive EWS result.   There was some evidence that MEWS 
may be slightly better at predicting who will die but worse at predicting who will not die 
than the NEWS score.  However, results from sensitivity analyses should be interpreted with 
extreme caution due to the small number of studies included in the review. 
 
Study quality was variable, with two studies rated as low risk of bias on all domain and, 
three studies rated as high risk of bias as there was it was possible that the EWS result was 
acted on prior and so could have affected the outcome. One study was available only as a 
conference abstract, and as such was judged at unclear risk of bias.  There were some 
concerns regarding applicability because of diagnosis of sepsis in one study, lack of 
information on when the EWS was performed in four studies, and in-hospital mortality 
rather than 30-day mortality as an outcome in one study. 
 
 
Strengths and weaknesses of this review 
Strengths of this review include a sensitive search strategy across multiple databases.  We 
therefore consider it unlikely that we have missed relevant studies.  We included a search of 
conference abstracts to minimise the likelihood of publication bias and contacted authors of 
included studies to ask them if they were aware of any additional studies.  It was not 
possible to formally assess publication bias as methods commonly used to detect this are 
not suitable for use in test accuracy reviews.19 However, publication bias may be less of a 
problem for studies of diagnostic test than for reviews of interventions. A recent study 
found that studies reporting higher accuracy were no more likely to be reported in full.28   
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Two reviewers were involved in all stages of the review process minimising the likelihood 
that bias or errors were introduced during the review process.  We used statistically robust 
hierarchical models to estimate summary sensitivity and specificity and to derive summary 
received operating characteristic plots.   These allow for both between-study variability in 
sensitivity and specificity, and the negative correlation between them.21 We used the 
validated QUADAS-2 criteria to assess study quality.  We incorporated the results of the 
quality assessment into our synthesis by restricting analyses to studies judged as low risk of 
bias or applicability.  
 
There are many variations of EWS using different scoring systems.  We included studies of 
any EWS in our review but only identified studies evaluating MEWS or NEWS.  Our analysis 
restricted to studies that had evaluated MEWS showed it was slightly better at predicting 
mortality than NEWS, but worse at ruling mortality out.  However, as only one study 
evaluated NEWS there were not sufficient data to allow firm conclusions regarding whether 
there is a difference in accuracy of these two scores.  As we did not identify studies of other 
EWS it is not possible to determine whether these might have differing accuracies from 
those EWS included in our review.   
 
Two new diagnostic criteria for sepsis have been published this year – US consensus 
guidelines (SEPSIS-3) and new guidance from NICE10,29. The SEPSIS-3 guidelines in particular 
differ quite significantly from the ACCP/SCCM definition used by the studies included in our 
review. Given the change in diagnostic criteria, the group categorised as having sepsis may 
well differ significantly from previous studies.  The accuracy of EWS for predicting mortality 
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in patients diagnosed according to new criteria may therefore not be the same as those 
diagnosed using previous diagnostic criteria.   
 
The treatment paradox – where the observed mortality may be significantly lower in studies 
where EWS are acted upon, is a high potential for bias in prospective studies introducing 
EWS. Three of our six studies were potentially at risk of this, although mortality in each of 
these studies was not substantially different from the other three studies (mean mortality 
22.7% vs 17.5%). 
 
 
Finally, and importantly, EWS were not designed to be used as single time point diagnostic 
or predictive tools. They are intended to be used to ‘track and trigger’ individual patients, 
and hence the evaluation of ‘one off’ EWS may not reflect day to day clinical practice.  
Estimates of accuracy from these studies therefore only show how accurate a single time 
point assessment of EWS is in predicting mortality.  Accuracy may be different if multiple 
time points were considered. However, we were unable to find any studies in sepsis 
evaluating EWS in any other context except ‘one off’ readings.  Alongside this, the timings of 
the particular EWS measurement were not clear in many of the studies (i.e. if they were the 
first or the worst set of observations taken). Given the dynamic nature of sepsis, and 
heterogeneous nature of EWS usage in these studies, this is an important consideration. 
 
Comparisons with previous literature 
We are unware of any other systematic review that have evaluated EWS in patients with 
sepsis. Previous literature around EWS in other patient populations has been studied more 
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extensively. A review conducted in 201430 found that EWS can predict cardiac arrest or 
death in patients on hospital wards, estimating an area under the curve of between 0.88-
0.93  based on eight studies, but noted significant methodological limitations in the studies. 
Another review of EWS for predicting mortality, also published in 2014, was unable to draw 
conclusions due to substantial heterogeneity of EWS systems alongside poor methodology31. 
One study, by Quan et al was identified as a conference abstract but did not have enough 
extractable data to be included in the formal SR. This was a retrospective study of ED 
patients with sepsis, that showed an area under the curve of 0.61 (0.52-0.70) for predicting 
mortality, but we were unable to gather any further information (despite emailing the lead 
author)32. 
 
We are aware of two further primary studies on early warning scores in specific infections 
rather than sepsis. One study has been published on EWS in Gram-negative bacteraemia33. 
This study collected EWS data for multiple days prior to and after the onset of bacteraemia, 
and found cumulative EWS scores (over multiple days) to be highly predictive of mortality 
(AUC 0.90, for a 7 day average of EWS after onset of bacteraemia). Another study looked at 
standardised early warning scores (SEWS) in patients with pneumonia34. This study included 
419 patients with pneumonia, and found a sensitivity of 52% and specificity of 67% for 
predicting mortality, similar to our study 
 
Implications for practice 
This review suggests that EWS cannot be used to predict who will or will not die in patients 
with sepsis, although the quality of studies was poor.  This is important for two reasons. 
Firstly, we should not be using EWS alone to prognosticate in patients with sepsis. They are 
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not accurate enough to guide treatment decisions alone (on this data), such as whether or 
not patients should be admitted to ITU or remain on wards.   
 
Secondly, EWS is now commonly used in the triage of patients presenting to healthcare 
facilities at different levels such as primary care or ED in the secondary / tertiary care 
hospitals. This approach is now endorsed by NICE for patients with ‘suspected sepsis’, based 
on the assumption that these scores predict mortality and other outcomes, and was a 
principal recommendation in the 2015 NCEPOD report on sepsis.  Although this review did 
not look at the predictive value of EWS in the setting of ‘suspected sepsis’, it would seem 
likely that EWS will have a poor performance in this group too, given that EWS does not 
predict mortality in sepsis.  
 
Therefore, EWS is not likely to be sensitive or specific enough to perform a triaging role 
alone, and is likely to lead to a significant increase in resources spent on low risk patients 
with suspected sepsis (if a low cut off is used), or missing of patients with a high mortality (if 
a high cut off is used).  
 
Implications for Research 
As noted above, there have been two new consensus guidelines on diagnosis of sepsis 
published this year10,29. It will be important to re-assess tools such as EWS in patients 
diagnosed with sepsis based on these new criteria, as they may perform quite differently. 
Secondly, there has been a gradual introduction of NEWS in the ambulance services and the 
community in the U.K, and research might be best to concentrate on NEWS in particular, 
alongside research comparing this to other EWS. 
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 Hence, large scale, multi-centre studies are needed to further assess the role of EWS in 
sepsis in the community and in ambulance or similar services. Further research would also 
be useful in patients with suspected sepsis, and perhaps in using multiple recordings of EWS 
in an emergency department stay to assess response to early treatment.  
 
Conclusions 
EWS have poor prognostic value in predicting sepsis mortality. Based on the existing data, 
which is of poor quality, EWS should not be used on their own to guide prognosis in patients 
with sepsis, and are unlikely to be reliable alone in identifying patients at risk or death. 
Further work is needed to assess the role of EWS in patients with suspected sepsis. 
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Patients were not involved in the design or conduct of this study. 
Figure 1: Flow of studies through the review process 
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Figure 2: Summary receiver operating characteristic plot for all studies  
Circles indicate individual study estimates; the green line shows the hierarchical summary 
receiver operating characteristic curve, the black square denotes the summary estimate and 
the dashed line its 95% confidence region, while the dotted line shows a 95% prediction 
region 
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Figure 3: Summary receiver operating characteristic plot for studies that evaluated MEWS 
Circles indicate individual study estimates; the green line shows the hierarchical summary receiver 
operating characteristic curve, the black square denotes the summary estimate and the dashed line 
its 95% confidence region, while the dotted line shows a 95% prediction region 
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Figure 4: Flow diagram showing the results that would be obtained if EWS were used in a 
hypothetical population of 1000 patients presenting with sepsis where 150 (15%) will die.  
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Table 1 Study details and individual study results 
Study and Country How sepsis 
diagnosed? 
EWS  Sepsis 
definition 
Threshold Setting n Mean/ 
median age 
% 
male 
Mortality 
prevalence 
(%) 
AUC  
(95% CI) 
Sensitivity (%) 
(95% CI) 
Specificity (%) 
(95% CI) 
LR+ 
(95% CI) 
LR- 
(95% CI) 
Cildir (2013) 
27 
Turkey  
Prospective, 
clinician 
identification 
MEWS ACCP/SCC
M 
≥6 ED 
 
230  NR NP 32.2 0.61 (NR) 43 (32, 55) 75 (67, 81) 1.73 (1.19, 
2.52) 
0.76 (0.62, 
0.93) 
Corfield (2014) 
22
 
Scotland 
 
Retrospective 
case note 
review 
NEWS ACCP/SCC
M 
≥5 ED 
 
2003  72  
(IQR 59, 81)  
47% 14.8 0.70 
(0.67, 
0.74) 
89 (85, 92) 30 (28, 32) 1.27 (1.22, 
1.34) 
0.33 (0.24, 
0.47) 
Geier (2013) 
24
 
Germany  
Prospective 
clinician 
identification 
and 
retrospective 
case note 
review. 
MEWS Clinical 
diagnosis 
≥5 ED  
 
151 68.3  
(SD 18)  
54 14.6 0.64 
(0.55, 
0.73) 
43 (22, 67) 74  
(63, 81) 
1.64  
(0.90, 
3.00) 
0.77  
(0.50, 
1.15) 
Ghanem, Zoubi 
(2011)
 25
 
Israel 
Prospective 
Electronic 
identification 
MEWS ACCP/SCC
M 
≥5 IM 
 
1072  74.7  
(SD 16.1) 
54% 19.4 0.67 
(0.63, 
0.71) 
60 (51, 69) 68 (64, 71) 1.88 (1.58, 
2.23) 
0.59 (0.47, 
0.73) 
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La Regina (2014) 
26
 
Italy 
 
Unknown MEWS Unknown ≥4 IM 
 
535 73  49% 14.4 0.59 
(0.51, 
0.66) 
34 (27, 45) 84 (80, 87) 2.06 (1.42, 
3.0) 
0.79 (0.67, 
0.93) 
Vorwerk (2008) 
23
 
UK  
Retrospective, 
case note 
review. 
MEWS Clinical + 
blood 
culture 
≥5 ED 
 
307  69.7  
(IQR 67.5, 
71.8) 
51% 23.4 0.72 
(0.67, 
0.77) 
72 (60, 82) 59  (53, 65) 1.76 (1.43, 
2.18) 
0.47 (0.32, 
0.69) 
(n= number of participants, AUC = area under curve, Prevalence = prevalence of mortality, NR = not reported, ED= emergency department, IM= internal medicine, MEWS = modified early 
warning score, NEWS = National early warning score) 
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Table 2 Results of the QUADAS-2 assessment 
 
Study RISK OF BIAS APPLICABILITY CONCERNS 
PATIENT 
SELECTION 
INDEX 
TEST 
REFERENCE 
STANDARD 
FLOW AND 
TIMING 
PATIENT 
SELECTION 
 
INDEX TEST REFERENCE 
STANDARD 
Cilder (2013)
 27
        ?  
Corfield (2014)
 22
        
Geier (2013)
 24
        ?  
Ghanem-Zoubi (2011)
 25
        
La Regina (2014)
 26
   ?   ?      ?   ?   ?   ? 
Vorwerk (2008)
 23
        ?  
Low Risk High Risk   ? Unclear Risk  
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Table 3 Summary estimates of sensitivity, specificity, and likelihood ratios (LR+ and LR-) for the primary analysis and sensitivity analyses 
 
 
Subgroup Number of 
studies 
Sensitivity (95% CI) Specificity 
(95% CI) 
LR+ 
(95% CI) 
LR- 
(95% CI) 
All studies 6 62 (45, 76) 66 (50, 79) 1.79 (1.53, 2.11) 0.59 (0.45, 0.78).   
Low risk of bias 2 72 (60, 82) and  
89 (85, 92) 
59 (53, 65) and  
30 (28, 32) 
1.76 (1.43, 2.18) &  
1.27 (1.22, 1.34) 
0.47 (0.32, 0.69) 
0.33 (0.24, 0.47) 
  
Low/unclear 
applicability 
concerns 
5 63 (41, 81) 65 (46, 80) 1.78 (1.47, 2.14) 0.57 (0.42, 0.78) 
ED only 4 67 (42, 85) 60 (40, 77) 1.65 (1.36, 2.00) 0.56 (0.38, 0.81) 
Threshold = 5 4 71 (51, 85) 58 (40, 74) 1.68 (1.37, 2.05) 0.50 (0.36, 0.69) 
MEWS only 5 52 (39, 65) 73 (39, 65) 1.90 (1.66, 2.18) 0.66 (0.55, 0.80) 
NEWS only 1 89 (85, 92) 30 (28, 32) 1.27 (1.22, 1.34) 0.33 (0.24, 0.47) 
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